Interim Results From Aastrom Biosciences, Inc. (ASTM)'s IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
11/16/2009 11:28:40 AM
More...
|
Aastrom Biosciences, Inc. (ASTM) to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
11/10/2009 12:27:54 PM
More...
|
Aastrom Biosciences, Inc. (ASTM) Reports First Quarter Fiscal Year 2010 Financial Results
11/6/2009 3:14:57 PM
More...
|
Harold C. Urschel, Jr., M.D. Joins Aastrom Biosciences, Inc. (ASTM)' Board of Directors
10/20/2009 8:45:01 AM
More...
|
Aastrom Biosciences, Inc. (ASTM) Receives Letter From NASDAQ Regarding Continued Non-Compliance With Minimum Bid Price Rule
10/7/2009 5:14:05 PM
More...
|
Aastrom Biosciences, Inc. (ASTM) to Present At Maxim Group Growth Conference
9/24/2009 9:48:17 AM
More...
|
Update On Aastrom Biosciences, Inc. (ASTM)'s Cardiovascular Programs to be Presented At Transcatheter Cardiovascular Therapeutics Annual Meeting by Amit N. Patel, M.D.
9/23/2009 10:21:27 AM
More...
|
Aastrom Biosciences, Inc. (ASTM) Reports Fourth Quarter and Fiscal Year 2009 Financial Results
9/15/2009 8:57:13 AM
More...
|
Aastrom Biosciences, Inc. (ASTM) Announces Transitions in Senior Management, Tim Mayleben to Become New CEO and CFO
9/4/2009 8:58:45 AM
More...
|
Aastrom Biosciences, Inc. (ASTM) to Present At BMO Capital Markets Healthcare Conference
8/3/2009 2:50:29 PM
More...
|
|